Skip to main content
. Author manuscript; available in PMC: 2016 Apr 20.
Published in final edited form as: Clin Nucl Med. 2014 Oct;39(10):874–881. doi: 10.1097/RLU.0000000000000539

Figure 5.

Figure 5

Figure A shows the 18FLT Time–activity-curve representing the average of all tumor target lesions, in which uptake is expressed in SUVest.max. Lymphoma showed rapid uptake of 18FLT, peaking at approximately 5 to 10, followed by relative plateau. Figure B shows the Patlak graphical analysis plot. Note the linearity consistent with irreversible binding.